Tomas Koch
Founder and Chairman @ TK & Partners
Tomas Koch is a seed investor at TK & Partners focused on Energy and Medical. Tomas Koch is theFounder and Chairman at TK&Partners.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Tomas Koch invests in
Stages Tomas Koch invests in
Countries Tomas Koch invests in
Investment Focus
Industry
- Energy 1 (33%)
- Medical 1 (33%)
- Health Care 1 (33%)
- Biotechnology 1 (33%)
- Machine Learning 1 (33%)
Country
- Singapore 1 (33%)
- United States 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Acurion
|
Acurion develops AI-driven diagnostic solutions that extract actionable genomic biomarker insights from standard pathology images to inform oncology treatment decisions. The company’s core product, OncoGaze™, analyzes digitized tumor biopsy slides to identify clinically relevant molecular features such as homologous recombination deficiency thatguide therapy selection more rapidly than conventional genomic testing. Acurion’s platform integrates into existing clinical workflows to support earlier precision medicine decisions for cancer care and is being expanded to detect additional biomarkers across various tumor types. The company collaborates with research and clinical partners to advance applications of its machine learning technology in oncology and related areas. | $4.3M / Seed / Apr 02, 2026 | |
|
Acurion
|
Acurion develops AI-driven diagnostic solutions that extract actionable genomic biomarker insights from standard pathology images to inform oncology treatment decisions. The company’s core product, OncoGaze™, analyzes digitized tumor biopsy slides to identify clinically relevant molecular features such as homologous recombination deficiency thatguide therapy selection more rapidly than conventional genomic testing. Acurion’s platform integrates into existing clinical workflows to support earlier precision medicine decisions for cancer care and is being expanded to detect additional biomarkers across various tumor types. The company collaborates with research and clinical partners to advance applications of its machine learning technology in oncology and related areas. | $2.1M / Seed / Jan 02, 2026 | |
HYDGEN
|
HydGen offers clean hydrogen solutions for an environmentally conscious future. | $1.5M / Seed / Feb 13, 2025 |
Co-Investors
Asian Fund For Cancer Research
1 deal together
Bootstrap Venture Partners
1 deal together
Cloudberry Pioneer Investments
1 deal together
Mesa Verde Venture Partners
1 deal together
National Foundation for Cancer Research
1 deal together
National University of Singapore
1 deal together
About TK & Partners
TK & Partners is a McKinsey venture capital firm.
TK & Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Tomas Koch
Founder and Chairman
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Tomas Koch invest in?
Tomas Koch invests primarily in Energy, Medical and Health Care startups, most often at Seed stage. Most of the 3 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Tomas Koch last invest?
The most recent investment recorded for Tomas Koch closed in Apr 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
